The NASDAQ stock exchange hasadded insult to injury to Medical Imaging Centers of America (MICA).The San Diego-based firm, already suffering from the high costof an expensive lease portfolio, announced last month that itsstock has been delisted from
The NASDAQ stock exchange hasadded insult to injury to Medical Imaging Centers of America (MICA).The San Diego-based firm, already suffering from the high costof an expensive lease portfolio, announced last month that itsstock has been delisted from NASDAQ.
MICA's stock was once a high flyer among publicly held imagingservice providers, with a price hovering around $14 a share. Thatprice had plummeted over the past several years to 50¢ ashare shortly before the stock was delisted.
MICA's dropping stock price and declining net worth ran afoulof NASDAQ's listing requirements, which mandate that a companyhave a stock price of over $1 and net worth of at least $4 million.MICA's net worth currently stands at about negative $3 million.
MICA's problems stem from the decline in reimbursement ratesand patient referrals that have hammered the imaging center industry.MICA's fee-for-service business was hit particularly hard, andas a result the firm has been left with a portfolio of expensiveequipment acquired in the late 1980s and early 1990s that doesnot fit the emerging health-care environment, according to chairmanand CEO Antone J. Lazos.
While the delisting is a black eye for MICA, the company'saggressive cost-cutting campaign is reducing its red ink. MICAhas cut personnel from 500 to 300 and is modernizing its technologyas quickly as possible. As old equipment comes off lease it isbeing replaced with more efficient scanners at better lease rates,Lazos said.
As a result, MICA's net loss fell from $1.9 million in thefirst quarter of 1993 to $662,000 in the first quarter of thisyear (end-March). Revenues dropped, from $18 million in the firstquarter of 1993 to $14.3 million in the same period this year.MICA runs 21 imaging centers in selected regions around the country.
MICA stockholders can continue to follow the company on theOTC Bulletin Board, where it will be listed under the stock symbolMIKA. MICA hopes to return to NASDAQ as soon as the company returnsto profitability, Lazos said.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.